Premium
Vismodegib resistant mutations are not selected in multifocal relapses of locally advanced basal cell carcinoma after vismodegib discontinuation
Author(s) -
Ighilahriz M.,
Benfodda M.,
Sharpe H.,
Soufir N.,
Mourah S.,
Dumaz N.,
Battistella M.,
Savina A.,
Bouquet F.,
Nikolaev S.,
BassetSeguin N.
Publication year - 2019
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/jdv.15741
Subject(s) - vismodegib , medicine , saint , basal cell carcinoma , discontinuation , basal cell , art history , art